AMED: Amedisys, Inc. - Summary | Jitta

Amedisys, Inc.

NASDAQ:AMED

Price
$92.59
Loss Chance
43.5%
5.11JITTA SCORE
29.70%Under Jitta Line
Jitta Ranking
124 / 1,176
1,657 / 5,155
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (52)
Recent Business Performance (26)
Financial Strength (81)
Return to Shareholders (48)
Competitive Advantage (58)
Jitta Signs
Debt LevelLow Long Term Debt
CapExVery Low
Interest Coverage RatioVery Good
Cash Conversion CycleLess than 60 days
Revenue and EarningEarning decline from 2019-2022
Operating MarginDeclined
Recent Business PerformanceEarning decline 26.86% in the last quarter (yoy)
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
5.11
29.70%
1.96
200.49%
Health Care Services
5.29
9.46%
3.41
4.11%
3.45
93.05%
COMPANY DESCRIPTION
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer’s. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.